Vendor: TDG Scientific
PrEST Antigen EIF3B eukaryotic translation initiation factor
|
$454.90 Original price was: $454.90.$369.24Current price is: $369.24.
Discount: 19% OFF
Recently Viewed Products
-
FD and C Red No. 3
$242.10Original price was: $242.10.$181.58Current price is: $181.58. -
Kaolin, Powder, FCC
$1,708.57Original price was: $1,708.57.$1,525.51Current price is: $1,525.51. -
HYDROCHLORIC ACID 1+50 SOLUTION (1L)
$33.29Original price was: $33.29.$21.35Current price is: $21.35. -
TRAP,BUMP,100ML,24/40,14/20
$168.87Original price was: $168.87.$141.91Current price is: $141.91.
Similar Products
More from this brand
PrEST Antigen ZBTB39 zinc finger and BTB domain containing 3
$454.90 Original price was: $454.90.$369.24Current price is: $369.24.
PrEST Antigen EPN2 epsin 2, 100ul UN 1687 6.1 PG2
$454.90 Original price was: $454.90.$369.24Current price is: $369.24.
PrEST Antigen GCN1 GCN1 eIF2 alpha kinase activator homolog,
$454.90 Original price was: $454.90.$369.24Current price is: $369.24.
PrEST Antigen RTN4IP1 reticulon 4 interacting protein 1, 100
$454.90 Original price was: $454.90.$369.24Current price is: $369.24.
PrEST Antigen RASAL1 RAS protein activator like 1 (GAP1 like
$454.90 Original price was: $454.90.$369.24Current price is: $369.24.
PrEST Antigen GGT2 gamma-glutamyltransferase 2, 100ul UN 168
$454.90 Original price was: $454.90.$369.24Current price is: $369.24.
PrEST Antigen C11orf87 chromosome 11 open reading frame 87,
$454.90 Original price was: $454.90.$369.24Current price is: $369.24.
PrEST Antigen TMEM123 transmembrane protein 123, 100ul UN 16
$454.90 Original price was: $454.90.$369.24Current price is: $369.24.
PrEST Antigen CASC4 cancer susceptibility candidate 4, 100ul
$454.90 Original price was: $454.90.$369.24Current price is: $369.24.
PrEST Antigen NLRP12 NLR family, pyrin domain containing 12,
$454.90 Original price was: $454.90.$369.24Current price is: $369.24.
PrEST Antigen RFLNB refilin B, 100ul UN 1687 6.1 PG2
$454.90 Original price was: $454.90.$369.24Current price is: $369.24.








